tradingkey.logo
tradingkey.logo
Search

Caribou Biosciences Inc

CRBU
Add to Watchlist
1.255USD
-0.035-2.71%
Market hours 09/24, 13:47ET
124.47MMarket Cap
LossP/E TTM

CRBU Financials

See Caribou Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
124.47M
Dividend TTM
0.00
P/E TTM
-0.89
EPS TTM
-1.42
Revenue
11.16M
Net Profit
-149.10M
ROE
-83.46%
ROA
-63.04%

Caribou Biosciences Inc Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
-0.24/-0.32
Revenue / Forecast
1.50M/2.28M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
58.65%-0.24
39.36%-0.26
28.03%-0.28
22.99%-0.30
-39.36%-0.58
6.55%-0.43
0.05%-0.39
-221.19%-0.38
13.18%-0.42
-0.74%-0.46
11.96%-0.39
---0.12
---0.48
---0.46
---0.44
----
----
----
----
----
Revenue
-43.79%1.50M
1.87%2.40M
89.74%3.94M
8.60%2.20M
-23.01%2.67M
-3.13%2.35M
-41.62%2.08M
-91.45%2.02M
-7.75%3.46M
-30.64%2.43M
-3.63%3.56M
616.38%23.66M
-10.42%3.75M
31.46%3.50M
44.28%3.69M
-16.95%3.30M
184.01%4.19M
67.97%2.66M
160.06%2.56M
231.97%3.98M
Net Profit
55.11%-24.28M
37.27%-25.09M
25.36%-26.49M
20.57%-27.55M
-43.51%-54.10M
3.01%-39.99M
-2.85%-35.49M
-246.77%-34.68M
-27.70%-37.70M
-47.03%-41.23M
-27.85%-34.51M
62.46%-10.00M
-10.57%-29.52M
-46.92%-28.04M
-46.05%-26.99M
-27.05%-26.65M
-86.55%-26.70M
-45.06%-19.09M
-25.68%-18.48M
-164.39%-20.97M
Net Margin
20.14%-1619.88%
38.42%-1046.52%
60.67%-672.11%
26.86%-1253.32%
-86.39%-2028.42%
-0.12%-1699.58%
-76.19%-1708.71%
-3954.00%-1713.64%
-38.43%-1088.25%
-111.98%-1697.57%
-32.66%-969.79%
---42.27%
---786.13%
---800.80%
---731.01%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Revenue
-43.79%1.50M
1.87%2.40M
89.74%3.94M
8.60%2.20M
-23.01%2.67M
-3.13%2.35M
-41.62%2.08M
-91.45%2.02M
-7.75%3.46M
-30.64%2.43M
-3.63%3.56M
616.38%23.66M
-10.42%3.75M
31.46%3.50M
44.28%3.69M
-16.95%3.30M
184.01%4.19M
67.97%2.66M
160.06%2.56M
231.97%3.98M
Operating profit
28.48%-25.34M
38.76%-26.28M
26.81%-28.45M
23.11%-29.40M
18.56%-35.43M
6.71%-42.91M
-3.83%-38.88M
-161.31%-38.24M
-32.35%-43.50M
-47.84%-46.00M
-22.45%-37.44M
44.86%-14.63M
-15.61%-32.87M
-49.22%-31.12M
-49.86%-30.58M
-42.55%-26.54M
-78.09%-28.43M
-58.28%-20.85M
-34.13%-20.41M
-126.22%-18.62M
Net Profit
55.11%-24.28M
37.27%-25.09M
25.36%-26.49M
20.57%-27.55M
-43.51%-54.10M
3.01%-39.99M
-2.85%-35.49M
-246.77%-34.68M
-27.70%-37.70M
-47.03%-41.23M
-27.85%-34.51M
62.46%-10.00M
-10.57%-29.52M
-46.92%-28.04M
-46.05%-26.99M
-27.05%-26.65M
-86.55%-26.70M
-45.06%-19.09M
-25.68%-18.48M
-164.39%-20.97M
Current assets
-39.43%116.59M
-43.69%122.38M
-33.80%145.23M
-34.50%155.51M
-28.93%192.51M
-28.63%217.32M
-35.26%219.38M
-32.30%237.43M
0.87%270.88M
27.15%304.51M
30.20%338.84M
14.26%350.69M
-23.91%268.54M
-34.92%239.49M
-33.47%260.25M
-31.65%306.92M
146.86%352.93M
136.02%368.01M
--391.19M
--449.05M
Total current liabilities
-37.78%17.97M
-30.95%19.67M
-17.09%25.41M
-12.75%28.06M
-6.65%28.89M
-1.83%28.49M
8.30%30.65M
30.88%32.16M
-9.98%30.94M
7.09%29.02M
0.62%28.30M
-14.72%24.57M
19.13%34.38M
1.62%27.10M
8.90%28.13M
10.15%28.81M
10.95%28.86M
20.07%26.67M
--25.83M
--26.16M
Total assets
-35.37%142.77M
-45.55%149.00M
-44.03%175.37M
-43.37%194.98M
-40.77%220.90M
-32.73%273.66M
-27.51%313.31M
-24.74%344.33M
6.66%372.94M
17.08%406.82M
15.64%432.21M
14.72%457.52M
-17.02%349.65M
-22.09%347.46M
-15.51%373.76M
-13.67%398.82M
166.02%421.37M
165.53%446.00M
--442.36M
--461.96M
Total liabilities
-18.44%44.67M
-16.75%46.98M
-11.88%53.19M
-15.83%53.14M
-12.33%54.77M
-11.18%56.43M
-5.40%60.36M
6.54%63.13M
-22.09%62.47M
-8.17%63.54M
-12.46%63.81M
-20.69%59.25M
9.13%80.19M
-6.75%69.19M
33.67%72.89M
29.80%74.71M
31.36%73.48M
38.68%74.20M
--54.53M
--57.56M
Total equity
-40.95%98.10M
-53.04%102.02M
-51.70%122.17M
-49.56%141.84M
-46.49%166.13M
-36.72%217.22M
-31.34%252.95M
-29.39%281.20M
15.22%310.46M
23.36%343.29M
22.44%368.40M
22.88%398.27M
-22.54%269.46M
-25.15%278.27M
-22.42%300.87M
-19.85%324.11M
239.54%347.89M
224.82%371.80M
--387.82M
--404.40M
Net operating income
19.36%-22.79M
26.52%-26.98M
41.29%-20.82M
22.89%-25.18M
14.02%-28.26M
1.28%-36.73M
-65.91%-35.47M
-13.45%-32.66M
-116.44%-32.87M
-33.16%-37.20M
14.63%-21.38M
-28.66%-28.79M
30.58%-15.19M
-28.91%-27.94M
-17.09%-25.04M
-49.50%-22.38M
-32.76%-21.87M
-206.70%-21.67M
-164.85%-21.39M
-72.21%-14.97M
Net investment
-21.19%18.94M
-51.43%23.98M
12.81%17.97M
-59.09%10.85M
13.38%24.04M
115.11%49.38M
150.61%15.93M
138.73%26.52M
91.61%21.20M
10.88%22.96M
-2790.09%-31.47M
-721.15%-68.48M
179.18%11.06M
128.71%20.70M
100.67%1.17M
-332.07%-8.34M
-2786.98%-13.97M
-327659.09%-72.11M
-28893.50%-173.96M
-48150.00%-1.93M
Net financing
298833.33%17.94M
476.07%2.70M
5.36%4.07M
13.52%277.00K
-95.45%6.00K
-96.25%468.00K
9083.72%3.86M
-99.82%244.00K
-99.25%132.00K
660.35%12.48M
-133.86%-43.00K
20561.77%135.13M
4753.87%17.57M
65.86%1.64M
-72.39%127.00K
-99.80%654.00K
-40.26%362.00K
-99.10%990.00K
460.98%460.00K
288009.82%322.68M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its total revenue reached 11.16M, with a year-on-year change of 9.99M.

What are the current assets of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its current assets were 145.23M, with a year-on-year change of -33.80.

What are the total assets of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its total assets of Caribou Biosciences Inc were 175.37M, with a year-on-year change of -44.03.

What are the total liabilities of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its total liabilities of Caribou Biosciences Inc were 53.19M, with a year-on-year change of -11.88.

What is the total equity of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its total equity of Caribou Biosciences Inc was 122.17M, with a year-on-year change of -51.70.

What is the net operating income of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its net operating income of Caribou Biosciences Inc was -136.19M, with a year-on-year change of 18.26.

What is the net investment of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its net investment of Caribou Biosciences Inc was 102.24M, with a year-on-year change of 18.05.

What is the net financing of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its net financing of Caribou Biosciences Inc was 4.82M, with a year-on-year change of -71.17.

What is the Earnings Per Share (EPS) of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.59, with a year-on-year change of 3.92.

What is the net income of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its net income was -148.12M, with a year-on-year change of 0.66.

What is the net margin of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its net profit margin was -1327.40, with a year-on-year change of 11.03.

What is the Return on Equity (ROE) of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -78.97, with a year-on-year change of -64.55.

What is the Return on Assets (ROA) of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -60.62, with a year-on-year change of -51.56.

What is the operating profit of Caribou Biosciences Inc?

According to Caribou Biosciences Inc's FY2025 earnings report, its operating profit was -136.19M, with a year-on-year change of 18.26.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.